drugset / Trial / NCT01390012

Oral Versus Intravenous Dexamethasone

NCT01390012 ↗

Phase 3 Completed 30 enrolled St. Antonius Hospital
RandomizedParallel-groupOpen-label

Summary

The purpose of this study is to assess bioequivalence for dexamethasone administered orally versus intravenously in patients admitted to hospital for pneumonia.

Timeline

Start
2011-08
Primary completion
2012-10
Completion
2012-10

Drugs

EvaluationDrugModalityDoseRoute
Comparator Dexamethasone Small molecule 4 mg Oral
Comparator Dexamethasone Small molecule 6 mg Oral

Indications